Clinical Trial Update: VELCADEXA: Velcade and Dexamethasone in Multiple Myeloma [Phase 2]

View source ↗

Summary

This is a Phase 2 trial evaluating Velcade (bortezomib) in combination with dexamethasone for multiple myeloma, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Velcade (bortezomib)

Snippet

Sponsor: PETHEMA Foundation | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED